Microbiology Testing Market Share

North American Market Forecast

Microbiology testing market in North America is projected to hold a share of about 32% by 2037. Market growth in the region is expected on account of the rising prevalence of food-borne illnesses owing to inadequate food processing. With the increasing contamination of food, there is a greater need for microbiology testing to identify and prevent these illnesses.

APAC Market Analysis

The Asia Pacific microbiology testing market is estimated to be the second largest, registering a share of about 28% by 2037. The market’s expansion is propelled by the rise in the geriatric population in the region. The increasing healthcare expenditure and rising awareness about microbiological testing benefits also influences the regional growth. The availability of advanced technologies such as PCR, and the rising number of NT-PCR testing as a result of surging COVID-19 cases, is further driving the microbiology testing market in region.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbiology testing is estimated at USD 4.84 billion.

The microbiology testing market size was valued at USD 4.59 billion in 2024 and is expected to cross USD 10.73 billion by the end of 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of infectious diseases, the rising demand for rapid and cost-effective tests will boost the market growth.

North America industry is projected to hold a share of about 32% by 2037, on account of the rising prevalence of food-borne illnesses in the region.

The major players in the market include Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, Cerner Corporation, Medtronic Plc, Stryker, iHealth Labs Inc., Cisco.

Microbiology Testing Market Share